A combined PD‐1/CTLA‐4 blockade dramatically (∼14‐fold) increased the trafficking of CD8+ T cells to the brain mainly through the upregulation of T cell entry receptors intercellular adhesion molecule 1 and vascular adhesion molecule 1 on tumor vasculature. This evidence concerns the gene CD8A and neoplasm.